HEALTHTHE RIO TIMES
Brazil Wants to Put Ozempic-Style Drugs in Its Public Clinics
Brazil’s health ministry plans to test Ozempic-style drugs in public clinics through a pilot program for 250 patients with severe obesity and heart complications in Porto Alegre. A government advisory body has rejected these drugs, but the trial is proceeding.
Mentioned
Related Signal
Adjacent reporting
- STAT+: Trump’s obesity drug plan creates a temporary Medicare program that may be hard to end
- STAT+: Pharmalittle: We’re reading about Medicare and obesity drugs, Germany’s pricing plans, and more
- STAT+: Pharmalittle: We’re reading about a PhRMA ad campaign aimed at 340B, sales of Novo’s obesity pill, and more
- Exclusive: Race begins to trial Ebola drugs amid current outbreak
- First human GLP-1 gene therapy trial gets green light